Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Abstract

Cultures of lactobacilli identified as Lactobacillus acidophilus from the intestinal contents of young calves varied in their ability to grow in broth containing .3% oxgall compared with control broth. Frozen concentrated cultures were prepared from a strain exhibiting low tolerance to bile and from a strain exhibiting high tolerance to bile. Plate counts were comparable from the concentrated cultures before and after frozen storage on lactobacilli MRS agar with and without .15% oxgall. In a feeding trial involving newborn dairy calves supplementation of the diet with the more bile resistant strain of Lactobacillus acidophilus caused greater increases of numbers of facultative lactobabilli in the upper small intestines than did the strain exhibiting lower resistance to bile. It was not possible to determine whether the lactobacilli would prevent intestinal infections in the calves challenged with enteropathogenic Escherichia coli. This portion of the study failed as the challenge with Escherichia coli did not cause infections even in control animals.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus acidophilusPrevention of Intestinal InfectionsNeutral
Small
Lactobacillus acidophilus HA-122Increased Facultative Lactobacilli in Upper Small IntestinesBeneficial
Moderate
Lactobacillus acidophilus MAK32L61AIncreased Facultative Lactobacilli in Upper Small IntestinesBeneficial
Moderate
Lactobacillus acidophilus NCIMB 30333Increased Facultative Lactobacilli in Upper Small IntestinesBeneficial
Moderate
Lactobacillus acidophilus R0418Increased Facultative Lactobacilli in Upper Small IntestineBeneficial
Moderate
Lactobacillus acidophilus UALa01Increased Facultative Lactobacilli in Upper Small IntestinesBeneficial
Moderate
Lactobacillus acidophilus UALa01Prevention of Intestinal InfectionsNeutral
Small
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Join Our Community
Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.